Paper35148751
Engineered exosomes as an in situ DC-primed vaccine to boost antitumor immunity in breast cancer.
Huang L and 10 others. Mol Cancer, 2022. Cited by 347 papers, by iCite.
Cite this record
ConductScience Library. Engineered exosomes as an in situ DC-primed vaccine to boost antitumor immunity in breast cancer. Papers, record 35148751. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35148751
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Engineered exosomes as an in situ DC-primed vaccine to boost antitumor immunity in breast cancer.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Breast Neoplasms | Major topic |
| Cancer Vaccines | Major topic |
| Exosomes | Major topic |
| Vaccines | Major topic |
| Animals | |
| Cell Line, Tumor | |
| Dendritic Cells | |
| Female | |
| Humans | |
| Leukocytes, Mononuclear | |
| Mice | |
| Tumor Microenvironment |
Source PubMed
References58
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 27558906 | Exosomes increase the therapeutic index of doxorubicin in breast and ovarian cancer mouse models. | Nanomedicine (Lond) | 2016 | https://conductscience.org/library/papers/27558906 | PubMed |
| 2 | 32661307 | Gold/alpha-lactalbumin nanoprobes for the imaging and treatment of breast cancer. | Nat Biomed Eng | 2020 | https://conductscience.org/library/papers/32661307 | PubMed |
| 3 | 32303573 | IFN-III is selectively produced by cDC1 and predicts good clinical outcome in breast cancer. | Sci Immunol | 2020 | https://conductscience.org/library/papers/32303573 | PubMed |
| 4 | 32941949 | CDK12/13 inhibition induces immunogenic cell death and enhances anti-PD-1 anticancer activity in breast cancer. | Cancer Lett | 2020 | https://conductscience.org/library/papers/32941949 | PubMed |
| 5 | 23569327 | Similar antigen cross-presentation capacity and phagocytic functions in all freshly isolated human lymphoid organ-resident dendritic cells. | J Exp Med | 2013 | https://conductscience.org/library/papers/23569327 | PubMed |
| 6 | 29224780 | A Living Biobank of Breast Cancer Organoids Captures Disease Heterogeneity. | Cell | 2018 | https://conductscience.org/library/papers/29224780 | PubMed |
| 7 | 29054784 | Developing a xenograft human tumor model in immunocompetent mice. | Cancer Lett | 2018 | https://conductscience.org/library/papers/29054784 | PubMed |
| 8 | 32764681 | Antitumour dendritic cell vaccination in a priming and boosting approach. | Nat Rev Drug Discov | 2020 | https://conductscience.org/library/papers/32764681 | PubMed |
| 9 | 29950349 | Therapeutic Immune Modulation against Solid Cancers with Intratumoral Poly-ICLC: A Pilot Trial. | Clin Cancer Res | 2018 | https://conductscience.org/library/papers/29950349 | PubMed |
| 10 | 31031762 | Personalized Dendritic Cell Vaccines-Recent Breakthroughs and Encouraging Clinical Results. | Front Immunol | 2019 | https://conductscience.org/library/papers/31031762 | PubMed |
| 11 | 31467405 | Dendritic cells in cancer immunology and immunotherapy. | Nat Rev Immunol | 2020 | https://conductscience.org/library/papers/31467405 | PubMed |
| 12 | 27939063 | Molecular alterations in triple-negative breast cancer-the road to new treatment strategies. | Lancet | 2017 | https://conductscience.org/library/papers/27939063 | PubMed |
| 13 | 17187072 | Calreticulin exposure dictates the immunogenicity of cancer cell death. | Nat Med | 2007 | https://conductscience.org/library/papers/17187072 | PubMed |
| 14 | 25001465 | Therapeutic vaccines for cancer: an overview of clinical trials. | Nat Rev Clin Oncol | 2014 | https://conductscience.org/library/papers/25001465 | PubMed |
| 15 | 32210954 | Engineered Tumor-Derived Extracellular Vesicles: Potentials in Cancer Immunotherapy. | Front Immunol | 2020 | https://conductscience.org/library/papers/32210954 | PubMed |
| 16 | 26014293 | Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma. | J Clin Oncol | 2015 | https://conductscience.org/library/papers/26014293 | PubMed |
| 17 | 31912821 | Photothermal therapy-induced immunogenic cell death based on natural melanin nanoparticles against breast cancer. | Chem Commun (Camb) | 2020 | https://conductscience.org/library/papers/31912821 | PubMed |
| 18 | 24188672 | Up to 15-year clinical follow-up of a pilot Phase III immunotherapy study in stage II breast cancer patients using oxidized mannan-MUC1. | Immunotherapy | 2013 | https://conductscience.org/library/papers/24188672 | PubMed |
| 19 | 31853056 | Tumor organoid-T-cell coculture systems. | Nat Protoc | 2020 | https://conductscience.org/library/papers/31853056 | PubMed |
| 20 | 26936504 | Dendritic cell vaccines based on immunogenic cell death elicit danger signals and T cell-driven rejection of high-grade glioma. | Sci Transl Med | 2016 | https://conductscience.org/library/papers/26936504 | PubMed |
Cited by236
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 347 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42936663 | Extracellular Vesicles in Breast Cancer: Immunomodulation, Biomarkers, and Therapy. | Int J Nanomedicine | 2026 | https://conductscience.org/library/papers/42936663 | PubMed |
| 42913016 | An in situ forming immunomodulatory hydrogel reinvigorates exhausted CD8+ T cells via preserving their mitochondrial fitness. | Sci Adv | 2026 | https://conductscience.org/library/papers/42913016 | PubMed |
| 42866611 | Engineered exosomes for breast cancer immunotherapy: Emerging strategies and translational potential. | Biochem Biophys Rep | 2026 | https://conductscience.org/library/papers/42866611 | PubMed |
| 42824691 | Biomimetic nano-in-gel vaccine platform with spatiotemporal co-delivery capacity for DC maturation against immunosuppressive tumors. | Int J Pharm X | 2026 | https://conductscience.org/library/papers/42824691 | PubMed |
| 42789159 | Current status of extracellular vesicle technology in industrialization and commercialization. | Discov Nano | 2026 | https://conductscience.org/library/papers/42789159 | PubMed |
| 42771161 | Smart drug delivery systems for immunotherapeutic agents: focus on biological/biogenic platform-based intelligent delivery in cancer immunotherapy. | Drug Deliv Transl Res | 2026 | https://conductscience.org/library/papers/42771161 | PubMed |
| 42733592 | Construction and application of mammary and breast cancer organoids. | Cell Insight | 2026 | https://conductscience.org/library/papers/42733592 | PubMed |
| 42711596 | Extracellular vesicles for next-gen therapeutics and drug delivery. | Mol Biomed | 2026 | https://conductscience.org/library/papers/42711596 | PubMed |
| 42630463 | Advances in the Research and Development of Breast Cancer Organoids. | Oncol Res | 2026 | https://conductscience.org/library/papers/42630463 | PubMed |
| 42500576 | Crosstalk between Extracellular Vesicles and the Tumor Microenvironment: Mechanistic Insights and Therapeutic Opportunities. | Oncol Res | 2026 | https://conductscience.org/library/papers/42500576 | PubMed |
| 42454198 | A multidimensional landscape of extracellular vesicle-mediated tumor drug resistance: mechanisms, biomarkers, engineered drug delivery, and clinical translation. | Extracell Vesicles Circ Nucl Acids | 2026 | https://conductscience.org/library/papers/42454198 | PubMed |
| 42434728 | A multi-level charged micelle-based microneedle transdermal system for immunosuppressive tumor microenvironment regulation and synergistic therapy. | Mater Today Bio | 2026 | https://conductscience.org/library/papers/42434728 | PubMed |
| 42325249 | Chimeric biohybrid nanovesicles induce immunogenic cell death for targeted and immune-potentiated glioblastoma therapy. | Asian J Pharm Sci | 2026 | https://conductscience.org/library/papers/42325249 | PubMed |
| 42273693 | Exosomes in inflammatory tissue injury: key pathogenic factors and promising therapeutic agents. | Front Immunol | 2026 | https://conductscience.org/library/papers/42273693 | PubMed |
| 42266701 | Overcoming immunotherapy resistance in triple-negative breast cancer: a critical review of mast cell plasticity, metabolic reprogramming, and organoid models. | Front Immunol | 2026 | https://conductscience.org/library/papers/42266701 | PubMed |
| 42193932 | The Organoid Decade: Leveraging 3D Patient-Derived Organoids to Bridge the Translational Gap in Triple-Negative Breast Cancer: A Systematic Review. | Cells | 2026 | https://conductscience.org/library/papers/42193932 | PubMed |
| 42133100 | The synergistic applications of organoids and exosomes in disease modeling and disease treatment. | Mol Biol Rep | 2026 | https://conductscience.org/library/papers/42133100 | PubMed |
| 42124939 | Establishment of Breast Cancer Organoids: A Systematic Review and Meta-Analysis. | Int J Breast Cancer | 2026 | https://conductscience.org/library/papers/42124939 | PubMed |
| 42063127 | The neuroimmune axis in breast cancer: from mechanistic insights to clinical applications. | BMC Med | 2026 | https://conductscience.org/library/papers/42063127 | PubMed |
| 42023220 | From immune desert to hot tumor: the tripartite synergy of tumor microenvironment-exosomes-immunogenic cell death in pioneering solutions. | Front Immunol | 2026 | https://conductscience.org/library/papers/42023220 | PubMed |
Genes33
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/35148751
GET https://conductscience.org/api/papers/v1/35148751/references?page=2